Clinical trial data from the Phase 2 trial published in the New England Journal of Medicine (Jastreboff et al., 2023) confirm that diarrhoea is among the most frequently reported adverse effects associated with retatrutide
Full support throughout your journey for life-changing results Full support throughout your journey for life-changing results Comprehensive support and proven methodology to help you reach your health goals with confidence
Always read the patient information leaflet before starting treatment
The findings, published in The New England Journal of Medicine , highlight the potential of GLP-1 receptor agonism combined with amylin analog therapy to deliver clinically meaningful weight loss beyond currently available treatments
Doctors must keep up with the newest techniques and best practices to ensure great results for their patients
After you eat, your body breaks down food into glucose, a type of sugar that enters your bloodstream